Literature DB >> 27252751

Jaw tumor in primary hyperparathyroidism is not always a brown tumor.

Laila Ennazk1, Ghizlane El Mghari1, Nawal El Ansari1.   

Abstract

Primary hyperparthyrodism (PHPT) is a common endocrine disease. It results from an inappropriate parathyroid hormone (PTH) secretion relative to serum ionized calcium level. Clinical manifestation of severe PHPT include bone disease called osteitis fibrosa cystica which reflects an increase osteoclastic resorption and osteoblastic activity. This high bone turnover is responsible of the occurrence of osteoclastomas, also named "brown tumors" (1). Rarely, PHPT may occur in inherited forms with association to fibrous jaw tumor that are unrelated to hyperparathyroidism. In this uncommon disease: hyperparathyroidism-jaw tumor (HPT-JT) syndrome, parathyroid tumor is frequently malignant and usually associated with nonendocrine malignancies (2). We report a case of a HPT-JT syndrome to focus on the differential diagnosis with brown tumors.

Entities:  

Keywords:  brown tumor; hyperparathyroidism-jaw tumor syndrome; ossifying fibroma; primary hyperparathyroidism

Year:  2016        PMID: 27252751      PMCID: PMC4869961          DOI: 10.11138/ccmbm/2016.13.1.064

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  6 in total

1.  A page out of the history of hyperparathyroidism.

Authors:  F ALBRIGHT
Journal:  J Clin Endocrinol Metab       Date:  1948-08       Impact factor: 5.958

2.  Primary hyperparathyroidism: evaluation of different treatments of jaw lesions based on case reports.

Authors:  G Knezević; V Uglesić; P Kobler; T Svajhler; M Bagatin
Journal:  Br J Oral Maxillofac Surg       Date:  1991-06       Impact factor: 1.651

Review 3.  Parathyroid carcinoma: a review.

Authors:  Randall P Owen; Carl E Silver; Phillip K Pellitteri; Ashok R Shaha; Kenneth O Devaney; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2011-03       Impact factor: 3.147

4.  Juvenile ossifying fibroma of the maxilla.

Authors:  R Breheret; C Jeufroy; E Cassagnau; O Malard
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2011-05-18       Impact factor: 2.080

Review 5.  Primary hyperparathyroidism.

Authors:  R Udelsman
Journal:  Curr Treat Options Oncol       Date:  2001-08

Review 6.  Parafibromin--functional insights.

Authors:  P J Newey; M R Bowl; R V Thakker
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.